Updates are available Correction dated 2021-01-05
Click to view Correction: https://doi.org/10.1007/s12928-020-00735-6
-
Authors
Suzuki, Satoru
Kaikita, Koichi
Yamamoto, Eiichiro
Jinnouchi, Hideaki
Tsujita, Kenichi
- License Information
-
More Information
Article History
Received: 7 October 2020
Accepted: 8 October 2020
First Online: 27 October 2020
Change Date: 5 January 2021
Change Type: Correction
Change Details: Correct Fig. 3 and
Compliance with ethical standards
:
: Dr. Kaikita has received significant research grant support from Bayer Yakuhin, Ltd., Daiichi Sankyo Co., Ltd., and has received Honoraria from Bayer Yakuhin, Ltd. and Daiichi Sankyo Co., Ltd. Dr. Tsujita has received honoraria from Amgen Astellas BioPharma K.K., Kowa Pharmaceutical Co. Ltd., Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Pfizer Japan Inc., Bristol-Myers K.K., and MSD K.K.; trust research/joint research funds from Bristol-Myers K.K., Sugi Bee Garden Co., LTD., and Kowa Pharmaceutical Co. Ltd.; and grants from ITI Co., Ltd., Abbott Medical Japan L.L.C., Abbott Vascular Japan Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Cardinal Health Japan., Kaneka Medix Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma, Chugai Pharmaceutical Co., Ltd., TERUMO Co., Ltd., NIPRO CORPORATION., NIHON KOHDEN CORPORATION., Medtronic Japan Co., Ltd., Japan Lifeline Co., Ltd., Fides-One, Inc., Fukuda Denshi Co., Ltd., and Boston Scientific Japan K.K.
